爱博医疗收盘上涨1.82%，滚动市盈率40.26倍，总市值152.21亿元

Group 1 - The core viewpoint of the articles highlights the performance and valuation of Aibo Medical, which closed at 78.7 yuan with a PE ratio of 40.26, marking a new low in 13 days, and a total market capitalization of 15.221 billion yuan [1] - Aibo Medical ranks 78th in the medical device industry based on PE ratio, with the industry average at 56.56 and the median at 39.76 [1][2] - As of March 31, 2025, Aibo Medical has 9,729 shareholders, a decrease of 94 from the previous count, with an average holding value of 352,800 yuan and an average shareholding of 27,600 shares [1] Group 2 - Aibo Medical specializes in the research, production, sales, and related services of ophthalmic medical devices, with key products including artificial lenses, surgical products, orthokeratology lenses, myopia control products, contact lenses, and other vision care products [1] - In the latest quarterly report for Q1 2025, Aibo Medical reported revenue of 357 million yuan, a year-on-year increase of 15.07%, while net profit was 92.558 million yuan, reflecting a year-on-year decrease of 10.05%, with a gross margin of 64.60% [1]